MPARX

Maine Pharmacy Association

DHHS shared guidance documents for e-prescribing and opioid dispensing

DHHS shared guidance documents for e-prescribing and opioid dispensing.  Notably, “A pharmacist is NOT required to verify that a practitioner has a waiver of the requirement to electronically prescribe…” To review the official documents, please click on the links below. Electronic-Prescribing-Clarifications Opioid Dispensing Clarification    

E-Prescribing Grace Period Notice and Chapter 488 User Guide

The deadline for mandatory e-prescribing of opioids was rapidly approaching on July 1st. However, the State sent the following communication announcing a 31 day grace period for enforcement of the penalties for violating the e-prescribing provision.  This is good news and will give prescribers and dispensers a little more time to prepare. DHHS provided material on other provisions in Chapter […]

2017 Scholarship Golf Scramble

Join us for our 2017 Scholarship Golf Scramble ! Where: Val Halla Country Club When: Saturday, August 12, 2017 Shotgun start 1pm Includes 18 holes of golf on a championship course, golf cart, BBQ dinner at Rachel’s on the Green! Cost: Single Golfer: $110.00 Foursome: $400.00 Dinner Only: $35.00 Corporate or personal hole sponsorship: $75 […]

Pharmacists from across Maine convene in Augusta to advocate for profession and patients

Pharmacists and pharmacy students from across the state convened in Augusta on May 30th to advocate for LD 572.   Update: Senate passes LD 572; now on to the House!  LD 572 specifies in statute that the “Practice of Pharmacy” is “the provision of health care services” and that “Pharmacists” are “providers of health care services”. […]

LD6 and LD44 Are Successfully Moving Through the Legislative Process

Good news!!  Two bills, LD 6, an “An Act to Prohibit Insurance Carriers from Retroactively Reducing Payment on Clean Claims Submitted by Pharmacies” and LD 455, “An Act Relating to the Provision of Smoking Cessation Services by Pharmacists” are moving through the legislature process. LD 6, an “An Act to Prohibit Insurance Carriers from Retroactively Reducing Payment on […]

Ms. Arnold spoke at the Partnership for Safe Medicine’s Interchange 2013 Conference in Washington, DC, Amelia Arnold, PharmDabout the events in her state that resulted in the passage of a controversial law that allows non-FDA approved medication to be imported from unregulated sources into the state of Maine.

At the heart of this recent law is a Canadian business called CanaRX that Ms. Arnold stated “came into Maine with a marketing scheme that bowled over legislators and employees unions.”

She pointed out that CanaRX’s claim that their pharmaceuticals are only sourced from Canada, Ireland, New Zealand, and Australia hides the fact that the drugs may originate far from these countries. She went on to say that these drug imports are not being tested or verified by any Maine medical professional, stating, “This legislation gives Maine Pharmacy Association no control to oversee CanaRX operations.”

As she explained to PBS during a recent interview, “Who’s going to find out that the pharmacy’s legitimate? Those companies can participate in what we call parallel importation. So they can get their drugs from other countries. So just because it’s coming into the U.S. from Canada doesn’t mean that it started in Canada.”

Ms. Arnold is also a member of the Maine Pharmacy Association, whose statement on Maine’s drug importation law makes quite clear the dangers posed to consumers by such legislation:

“Despite our best efforts to educate lawmakers about the real public health risks of illegal Rx drug importation, the Maine 126th legislature passed a bill, LD 171, which allows an unlicensed ‘entity’ (e.g., a broker in another country) to import Rx drugs from Canada, UK and Northern Ireland, Australia or New Zealand into Maine. This ‘entity’ is ‘exempt from licensure’ and thus any regulatory oversight. This new law does not provide patients in Maine with any recourse if a counterfeit or adulterated prescription drug is shipped to their home. The scope of this new law could even include controlled, addictive Rx drugs. Patients lives are at risk.”

Leave a Reply

You must be logged in to post a comment.